Enoxaparin Sodium (Watson Pharma, Inc.)
Welcome to the PulseAid listing for the Enoxaparin Sodium drug offered from Watson Pharma, Inc.. This Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Watson Pharma, Inc. |
NON-PROPRIETARY NAME: | Enoxaparin Sodium |
SUBSTANCE NAME: | ENOXAPARIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-01-27 |
END MARKETING DATE: | 0000-00-00 |
Enoxaparin Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Enoxaparin Sodium from Watson Pharma, Inc. |
LABELER NAME: | Watson Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/.3mL) |
START MARKETING DATE: | 2012-01-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62037-839_087671b1-df17-4c94-b1be-6c491b50db1d |
PRODUCT NDC: | 62037-839 |
APPLICATION NUMBER: | ANDA076684 |
Other ENOXAPARIN SODIUM Pharmaceutical Manufacturers / Labelers: